Reducing hyperglucagonaemia in type 2 diabetes using low-dose glibenclamide: Results of the LEGEND-A pilot study. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/dom.14740
PubMed Identifier: 35491519
Publication URI: http://europepmc.org/abstract/MED/35491519
Type: Journal Article/Review
Volume: 24
Parent Publication: Diabetes, obesity & metabolism
Issue: 8
ISSN: 1462-8902